Dr Zsofia Stadler

Dr. Stadler is Clinic Director of the Clinical Genetics Service with a primary appointment in Clinical Genetics and a secondary appointment in the Gastrointestinal Medical Oncology Service at Memorial Sloan-Kettering Cancer Center (MSK).

She completed her medical training at Cornell University followed by internal medicine residency at Brigham and Women’s Hospital and medical oncology fellowship at Beth Israel Deaconess Medical Center in Boston, where her research focused on clinical cancer genetics and hereditary cancer syndromes. Dr. Stadler joined MSK in 2008, where she is now an Associate Attending Physician and is also appointed as an Associate Professor of Medicine at Weill Cornell Medical College.

Her clinical focus is on the diagnosis, treatment, and management of patients and families with an inherited genetic predisposition to gastrointestinal cancers with a special focus on Lynch syndrome. Her research interests focus on the identification of new cancer susceptibility genes through the use of genomic technologies and the development of novel approaches to cancer screening and prevention in high-risk families.

She serves as co-PI of MSK’s tumor-normal IMPACT sequencing protocol overseeing agnostic germline sequencing encompassing over >44,000 cancer patients.